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A BSTRACT 
Disorders of sex development (DSD) is defined by congenital conditions in which 
development of chromosomal, gonadal, or anatomical sex is atypical, while in clinical 
practice this term means any abnormality of the external genitalia. DSD patients have been 
managed by a multidisciplinary gender team in our center as collaboration between Dr. 
Kariadi province referral hospital and Faculty of Medicine Diponegoro University. 
Diagnosis should be established by specific physical examination hormonal, chromosomal 
and DNA studies; and imaging for most of the cases depending on indication.  
Since 2004 the involvement of molecular and cytogenetic analysis so far can diagnosed 
many of the DSD cases. Most of the genetically proven cases were Congenital Adrenal 
Hyperplasia, Androgen Insensitivity syndrome and sex chromosomal DSD that lead 
abnormal gonadal development.  Many of them remain undiagnosed, further testing such as 
advanced DNA study should be carried out in collaboration with other center in overseas.  
The novel genes were found in some cases that contributed for the management of DSD.  
Information for medical professionals, patients, family members and community about the 
availability and necessity of DSD diagnosis should be delivered to improve DSD 
management and patient quality of life. 
 
INTRODUCTION 
Disorder of Sex Development (DSD) formerly 
termedintersex, hermaphrodite, or ambiguous 
genitalia. This group of conditions now is being 
called disorders of sex development (DSDs) 
according to "Consensus statement on management 
of intersex disorders"1. DSD is divided into three 
primary roots based on karyotype namely 46,XX; 
46,XY and Sex Chromosome DSD. Secondary root 
is depicted based on hormone assessment and 
imaging and the tertiary root is obtained based on 
molecular and/or histopathology examination. 
Classification of sex chromosome DSD include the 
following:45,X (Turner syndrome and variants); 
47,XXY ( Klinefelter syndrome and variants) and 
45,X/46,XY (mixed gonadal dysgenesis, 
ovotesticular DSD); 46,XX/46,XY (chimeric, 
ovotesticular DSD). Classifications of 46,XY DSD  
 
 
clude the following:disorders of testicular 
revious Terminology and Revised 
 
 
in
development (complete and partial gonadal 
dysgenesis); disorders of androgen synthesis 
(complete and partial androgen insensitivity; 
disorders of anti mullerian hormone/ AMH, 
androgen biosynthesis defect) and other (severe 
hypospadias, cloacalexstrophy). Classifications of 
46,XX DSD include the following:disorders of 
ovarian development (ovotesticular DSD, testicular 
DSD, gonadal dysgenesis) and Androgen excess 
(fetal Congenital Adrenal Hyperplasia/ CAH) and 
other ( vaginal atresia, cloacalexstrophy).  
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The ability to diagnose these conditions has 
advanced rapidly in recent years cases 
clinicians in developed countries can promptly 
ma
tation 
of 
t 
enyesuaianKelamin) team in our center is the 
that 
ma
osomal 
and
gen
he 
dis
. In most 
ke an accurate diagnosis and counsel parents on 
therapeutic options. However early gender 
assignment and reconstruction surgery has been 
challenged because of the dilemma of gender 
identity development in later life. Molecular 
analysis as part of health care service in Indonesia 
is limited in research center of the universities 
setting; therefore a complete diagnosis with genetic 
analysis quite often cannot be done. Proper 
diagnosis and integrated treatment is important for 
DSD patient, in order to avoid medical, 
psychological and social aspect in adult life.  
Hughes  identified quite a lot of gene mutation 
in 46, XY DSD 2. Significant number of gene 
mutation in 46, XY with  the clinical presen
undervirilisation or  gonadal dysgenesis  were 
found by our group such as DAX-1 duplication, 
SF1 mutation and other more common mutation 
such AR gene and Cyp 21 mutation 3,4,5.  Studies 
from a number of different countries and cultural 
differences showed that while many patients 
managed sequentially, gender counseling as well as 
sexual counseling should be part of the multi-
disciplinary service available to patients with DSD 
to avoid gender dysphoria6. Genetic counseling is 
not very common as part of health care in 
Indonesia, however it should be also given to 
patient and family as many DSD is actually caused 
by inherited genetic diseases7.  Urological 
problems and prevention to the development of 
malignancy in both males and females with DSD 
deserve more attention8.  The Ministry of Health of 
the Indonesian government should pay more 
attention to the management of DSD cases; provide 
diagnostic facilities and treatments such as 
hormonal and glucocorticoid medication. The 
challenges for the future will include the further 
investigation of the gene mutation influenced to 
sex development that relevant with clinical 
implications.  International collaboration with 
multidisciplinary expertise should be encouraged. 
 
Services and Genetic analysis in our center 
The gender team called as Sexual adjustmen
(P
only multidisciplinary team in Indonesia 
nages patients with DSD. This collaborative 
team between Dr Kariadi province referral hospital 
and Faculty of Medicine Diponegoro University is 
consisted of experts in urology surgery, plastic 
surgery, gynecology, anesthesiology, Adult and 
Child endocrinology, genetics, andrology, 
psychiatry, psychology, pathology, legal , religion 
and social-medical staff.  The process of 
establishing the correct diagnosis starts with serial 
hormonal and genetic testing then referring the 
patients and family to the multidisciplinary team 
for further analysis of possible treatments.  
Patients were referred to Center for Biomedical 
Research, Faculty of Medicine Diponegoro 
University, Semarang, Indonesia for chrom
 gene analysis. Before drawing the blood all 
patients were physically examined for specific 
DSD. Diagnosis were firstly established using 
chromosome and common hormonal analysis such 
as testosterone, LH, FSH, and 17 OH progesterone. 
Genetic analysis has been done for chromosome 
analysis, rarely FISH analysis, some gene analysis 
such as SRY gene, AZF gene, AR gene and Cyp21 
e. Chromosomal aberrations were the most 
common found of DSD cases in the first line of 
diagnosis. Other advanced and scarce gene 
mutations have been done in collaboration with 
other center in overseas on the basis of joint 
research.  Most of the cases were 46, XY DSD 
followed by 46, XX DSD andSex Chromosomal 
DSD respectively. The genetically proven 46, XY 
DSD cases were Androgen Insensivity Syndrome ( 
AR gene mutation) and the majority cases of 46, 
XX DSD were Congenital Adrenal Hyperplasia. 
Many stages and genes are involved that lead to 
gonadal formation and differentiation, thus it is not 
always possible to identify the causes of t
orders. Consequently, the scope of molecular 
genetic analysis has markedly expanded. Although 
clinical and psychological management have 
already been done, many undiagnosed DSD should 
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be later analyzed using advanced molecular 
techniques. Recommendations on what is needed 
in the diagnosis and management of DSD should 
be promoted among medical community including 
the obstetrician. Many primary care doctors 
unaware to such laboratory testing and it is 
unavailable in all regency hospitals (type B 
hospitals) in Indonesia. These genetic testing is not 
affordable and not covered by the government 
health insurance (BPJS) because it is not known 
and not a priority by the government stake holder 
who manages the government public insurance. 
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